Albayati DIR, Oday Hatem DA. Effectiveness and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis among Iraqi Patients. WOS [Internet]. 2025 Mar. 17 [cited 2025 Mar. 18];2(3):86-91. Available from: https://wom.semanticjournals.org/index.php/biomed/article/view/322